101. Estrogen therapy affects right hemisphere functioning in postmenopausal women.
- Author
-
Bayer U and Hausmann M
- Subjects
- Affect drug effects, Aged, Analysis of Variance, Cerebrum drug effects, Estradiol therapeutic use, Estrogens analysis, Estrogens therapeutic use, Female, Humans, Luminescence, Middle Aged, Neuropsychological Tests, Progestins analysis, Progestins therapeutic use, Psychomotor Performance, Reaction Time, Saliva chemistry, Surveys and Questionnaires, Cerebrum physiology, Estrogen Replacement Therapy, Functional Laterality drug effects
- Abstract
It has been suggested that hormone therapy (HT) in postmenopausal women differentially affects verbal and visuo-spatial abilities which mainly rely on left hemisphere (LH) and right hemisphere (RH) functioning, respectively. Thus, it seems likely that HT-related effects on cognition are driven by associated hormonal changes and their impact on functional brain organization, and functional cerebral asymmetries (FCAs) in particular. The present study investigated HT-related effects on FCAs in sixty-seven postmenopausal women who received hormone therapy either with estrogen (E) alone (n=14), an E-gestagen combination (n=22) or without HT (control group, n=31). Saliva levels of free E and progesterone (P) were analyzed using chemiluminescence assays. FCAs were measured with the visual half-field (VHF) technique using a word matching and a figural comparison task. In agreement with previous results, a postmenopausal control group showed a left hemisphere (LH) advantage in the verbal task and a right hemisphere (RH) advantage in visuo-spatial processing. In contrast, both HT groups revealed significantly reduced FCAs in the figural comparison task as a result of an E-related decrease in RH performance. The findings suggest that E-therapy in postmenopausal women can affect visuo-spatial abilities by modulating the functional brain organization and RH functioning in particular.
- Published
- 2009
- Full Text
- View/download PDF